BRIEF-Arcus Outlines Plans For Casdatifan And Its Inflammation Programs

Reuters
Jan 08
BRIEF-Arcus Outlines Plans For Casdatifan And Its Inflammation Programs

Jan 7 (Reuters) - Arcus Biosciences Inc RCUS.N:

  • ARCUS BIOSCIENCES INC - PLANS THREE DATA READOUTS FOR CASDATIFAN IN 2026

  • ARCUS BIOSCIENCES INC - EXPECTS TO FUND OPERATIONS UNTIL SECOND HALF OF 2028

Source text: ID:nBw6m2tTza

Further company coverage: RCUS.N

((Reuters.Briefs@thomsonreuters.com;))

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10